Needle-free Injections
Total Trials
17
As Lead Sponsor
7
As Collaborator
10
Total Enrollment
6,746
NCT00450905
Pain Relief Investigation of Neuromodulation Therapy in an Adult Fibromyalgia Population
Phase: Phase 3
Role: Collaborator
Start: Mar 31, 2007
Completion: Dec 31, 2008
NCT00607386
Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy
Phase: Phase 4
Start: Dec 31, 2007
Completion: Jul 8, 2011
NCT00691522
Imaging Study of XERECEPT® Treatment for Peritumoral Brain Edema (PBE)
Phase: Phase 2
Role: Lead Sponsor
Start: Nov 30, 2008
Completion: Oct 31, 2009
NCT01093105
An Observational Study of Pediatric Subjects With Globoid Cell Leukodystrophy (GLD)
Phase: N/A
Start: Apr 1, 2010
Completion: May 1, 2012
NCT01134016
Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects
Phase: Phase 1
Start: Dec 31, 2010
Completion: Jun 30, 2013
NCT01236235
Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Start: Jan 31, 2011
Completion: Jul 31, 2013
NCT01388816
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels
Start: Jul 31, 2011
Completion: Jun 30, 2012
NCT01403116
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Completion: Sep 30, 2013
NCT01644149
Clinical Trial Assessing the Immunologic Response to a Influenza Vaccine Delivered Using an Jet Injection Device or a Needle Syringe
Start: Jan 31, 2012
Completion: Feb 29, 2012
NCT01688921
Jet Injection for Influenza
Start: Oct 31, 2012
Completion: Mar 31, 2013
NCT02090556
Long-term Experience With Abatacept SC in Routine Clinical Practice
Start: Mar 26, 2013
Completion: Jan 29, 2019
NCT02290691
Inactivated Influenza Via Jet Injection
Start: Nov 30, 2014
Completion: Jan 31, 2015
NCT03164772
Phase 1/2 Study of Combination Immunotherapy and Messenger Ribonucleic Acid (mRNA) Vaccine in Subjects With NSCLC
Phase: Phase 1/2
Start: Dec 20, 2017
Completion: Oct 29, 2021
NCT06002503
Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection
Start: Oct 16, 2023
Completion: May 31, 2025
NCT06142461
Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System
Start: May 31, 2024
Completion: Apr 30, 2025
NCT06919796
mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes
Start: May 1, 2025
Completion: Nov 25, 2026
Loading map...